SPARK acted as Financial and Nominated Adviser to Integumen plc

SPARK Advisory Partners Limited (“SPARK”) acted as Financial and Nominated Adviser to Integumen plc on its £2.25m fundraise and flotation on AIM.

Integumen is a personal health care company developing and commercialising technology and products for the human integumentary system that may improve physical appearance, hygiene and general health outcomes. The Group consists of four wholly-owned subsidiaries: UK-based Innovenn and Lifesciencehub, TSpro in Germany and Integumen Inc in the United States, the businesses of which were acquired via share-for-share transactions ahead of flotation. It is quoted on AIM under the ticker “SKIN”.